Clinical Trial

H1ssF Flu Vaccine Clinical Trial

Name: H1ssF Flu Vaccine Clinical Trial — clinical trial record (NCT07340047)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a two-arm, open-label, randomized, phase 1, controlled clinical trial intended to evaluate the safety and immunologic response to the experimental vaccine H1ssF (H1 stabilized stem ferritin nanoparticle) and the seasonal flu vaccine Flucelvax.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-05.

Trial Details

NCT Number	NCT07340047
Lead Sponsor	University of Minnesota
Conditions	Influenza
Enrollment	112 participants
Start Date	2026-08-01
Primary Completion	2028-03-01 (estimated)
Study Completion	2028-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-19